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Abstract
Background
Phylogenetically distinctMycobacterium tuberculosis lineages differ in their phenotypes
and pathogenicity. Consequently, understanding mycobacterial population structures phy-
logeographically is essential for design, interpretation and generalizability of clinical trials.
Comprehensive efforts are lacking to date to establish the West African mycobacterial pop-
ulation structure on a sub-continental scale, which has diagnostic implications and can
inform the design of clinical TB trials.
Methodology/Principal Findings
We collated novel and published genotyping (spoligotyping) data and classified spoligo-
types into mycobacterial lineages/families using TBLineage and Spotclust, followed by phy-
logeographic analyses using statistics (logistic regression) and lineage axis plot analysis in
GenGIS, in which a phylogenetic tree constructed in MIRU-VNTRplus was analysed. Com-
bining spoligotyping data from 16 previously published studies with novel data from The
Gambia, we obtained a total of 3580 isolates from 12 countries and identified 6 lineages
comprising 32 families. By using stringent analytical tools we demonstrate for the first time a
significant phylogeographic separation between western and eastern West Africa not only
of the twoM. africanum (West Africa 1 and 2) but also of several majorM. tuberculosis
sensu stricto families, such as LAM10 and Haarlem 3. Moreover, in a longitudinal logistic
regression analysis for grouped data we showed thatM. africanumWest Africa 2 remains a
persistent health concern.
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Conclusions/Significance
Because of the geographical divide of the mycobacterial populations in West Africa, individ-
ual research findings from one country cannot be generalized across the whole region. The
unequal geographical family distribution should be considered in placement and design of
future clinical trials in West Africa.
Author Summary
Tuberculosis is caused by bacteria belonging to theMycobacterium tuberculosis complex
(MTBc), which consists of seven major, phylogenetically distinct lineages and their fami-
lies. West Africa is the only region in the world where, besides the commonM. tuberculosis
lineages, the twoM. africanum lineages are endemic. We demonstrate that the composi-
tion of the mycobacterial population in the western part of West Africa significantly differs
from the one in the eastern part. This documented variation will impact on generalizability
and interpretation of clinical trials outcomes. Therefore future trial designs need to con-
sider the geographical diversity of underlying mycobacterial populations.
Introduction
West Africa consists of 15 countries with 245 million inhabitants (S1A Fig), 13 of which belong to
the world’s 42 countries with the lowest human development index [1]. Consequently, it faces great
challenges in controlling infectious diseases, such as tuberculosis (TB). Clinical trials investigating
the local health needs are much needed to understand and tackle the TB epidemic inWest Africa.
The composition of the endemic mycobacterial population infecting human study subjects can
have a major impact on TB clinical trial outcomes and should ideally be accounted for in the plan-
ning phase of any project [2]. Considering bacterial variation between study sites is also essential to
estimate to what extent country-specific results can be generalised to the whole of West Africa.
The MTBc can be divided into six major lineages, comprised of the Indo-Oceanic (L1),
East-Asian (L2), Central Asian (L3), Euro-American lineages (L4) and the two endemic Afri-
can lineagesM. africanumWest Africa 1 (MAF1, L5) andM. africanumWest Africa 2 (MAF2,
L6) [3]. Although MAF1 seems to be disappearing in some countries, the longitudinal develop-
ment of MAF2 is not known. Each of these phylogenetically distinct lineages can be further dif-
ferentiated into mycobacterial families, such as, amongst others, the Latin-American-
Mediterranean (LAM) or Haarlem families within the Euro-American lineage [3].
Interestingly and for reasons not understood, West Africa is the only region in the world in
which all of the six major human lineages are present. This exceptional diversity necessitates
future West African trials to be adjusted for this unique bacterial variability—even more than
trials in other parts in the world. Therefore the scope of the present publication was to describe
the geographical distribution and spatial variations of mycobacterial families across the region.
Methods
Search strategy and spoligotype analysis
We searched Pubmed using terms “spoligotype”, “spoligotyping” with respective country
names. Studies on pulmonary TB up to December 2014 were included, in which spoligotypes
on all isolates were available. Individual spoligotypes designated as mixed infections were
excluded. In case several publications analysed the same dataset, the most comprehensive
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collection was selected.M. bovis studies, conducted in high risk populations (abattoir staff)
were excluded. To assign mycobacterial families to isolates, and to ensure comparability
between different datasets, we re-analysed extracted spoligotype information using a standard-
ized approach. Isolates were classified into families using the online platform “Spotclust” at the
default settings. ForM. africanum isolates, Spotclust identifies, but does not distinguish
between MAF1 and 2. Therefore “TBLineage” was further applied toM. africanum isolates pre-
viously identified by Spotclust [4]. Both Spotclust and TB Lineage are mathematical algorithms
that were shown to reliably identify mycobacterial lineages and families based on respective sig-
nature spoligotype patterns. A detailed description of the algorithms and their performance is
described elsewhere [4,5]. The lineage/family distribution per country/study site was plotted as
chloropleth maps generated using QGIS 2.0.1 (http://qgis.osgeo.org).
Statistical analysis of geographical genotype distribution
To investigate geographical differences in mycobacterial families across West Africa we split
West Africa into a Western and an Eastern region. Western countries include Gambia,
Guinea-Bissau, Guinea, Sierra Leone, Ivory Coast, Mali, Senegal, while Eastern countries
include Benin, Burkina Faso, Ghana, Niger and Nigeria (S1 Fig). With region as response vari-
able, the proportion of each family was tested univariately using logistic regression, with coun-
try fitted as a cluster to account for multiple studies per site.
Families found in one region and not in the other cannot be modelled mathematically
because the maximum likelihood for these families does not exist. We defined families with
complete separation between regions as ‘perfect predictors’.
A two-sided p-value<0.05 was considered statistically significant and a two-sided p-value
0.05 &<0.10 was considered of borderline significance. No adjustment was made for multi-
ple testing. All analyses were performed using Stata v12.1 (StataCorp. 2011. Stata Statistical
Software: Release 12. College Station, TX: StataCorp LP.).
GenGIS analysis
Phylogeographic analysis using linear axis analysis in GenGISvs2.2.2 was conducted [6]. The
default GenGIS Africa map was used. A UPGMA phylogenetic tree was constructed from spo-
ligotyping data (S2 Fig) using the publicly available MIRU-VNTRplus software [7] and
uploaded into GenGIS allowing for the re-ordering of leaf nodes. A Linear axis plot (10.000
permutations) was run at significance level p = 0.001.
Longitudinal analysis of lineages in The Gambia
Gambian isolates, collected within a TB Case Contact cohort, in which all cases of the Greater
Banjul area are recruited [8] were spoligotyped. Genotyping was approved by the Gambian
Government/MRC joint ethics committee. Longitudinal lineage data was modelled using logis-
tic regression for grouped data. The outcome was the number of a particular lineage out of the
total number of samples taken in each year. Both lineage and year were fitted as explanatory
variables and interactions between the two explored. The multicollinearity between the lineages
was avoided by excluding one lineage and fitting the model on the remaining.
Results
TheM. tuberculosis complex in West Africa
Of 20 original research articles, four were excluded (based on above criteria), with the remain-
ing 16 covering 12 of 15 West African countries. In total we collected, extracted and (re)
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analysed spoligotype information of 3580 isolates, belonging to six major human lineages, of
which the Euro-American lineage (L4), together withM. africanum lineages (L5 and 6) were
the main causes of pulmonary TB (Table 1). Thirty-two different mycobacterial families were
identified, but 84% of all patients are infected by only eight major families (Fig 1).
Common to most of the countries is the “ill-defined” T1 family. We also confirmed the pre-
viously described geographical distribution of twoM. africanum lineages [24]. While MAF1
(L5) has the highest presence in Nigeria/Benin, MAF2 (L6) is mainly found in Gambia/
Guinea-Bissau. Besides MAF2 as a major cause for TB, a variety of Euro-American families
(Haarlem 1 and 3, LAM9, amongst others) are prevalent in western West Africa. This is in
sharp contrast to eastern West Africa where, besides MAF1, the great majority of TB infections
is attributable to only one other dominant family LAM10. A recently introduced family into
West Africa is the Beijing family which lead to an outbreak in Cotonou, Benin [25]. The only
other place with comparably high numbers of Beijing isolates is Dakar in Senegal. Both cities,
Dakar and Cotonou have major international ports.
Geographical distribution of mycobacterial families in West Africa
To evaluate whether identified families are geographically equal, we divided West Africa into a
Western and Eastern region (S1B Fig). Univariate logistic regression analysis showed that the
proportion of mycobacterial families can serve as predictors for the two regions. 13 out of 32
families were associated with one of the two regions (see S1 Table). Amongst these were four of
the eight major families: LAM10 (perfect predictor at proportion0.12) and MAF1 (p = 0.08)
as predictors for the East and Haarlem 3 (p = 0.07) and MAF2 (p = 0.09) for the West.
To verify the geographic separation of these four major families, which cause 51% of all TB,
we carried out an independent phylogeographic analysis using GenGIS software (Fig 2). We
constructed an UPGMA tree based on 279 unique Haarlem 3, MAF1/2 and LAM10 spoligo-
types, which was superimposed onto geographic locations and mycobacterial family distribu-
tions of the study sites (Fig 2A). In case of geographical separation, one expects significantly
less crossings between the phylogenetic tree and the spoligotype distribution in the study sites
than by mere chance. A linear axis analysis (p<0.001, 10.000 permutations) identified several
orientations of the tree’s geographical axis that resulted in less than the 9759.5 crossings
expected by chance. Fig 2B demonstrates that geographical separation occurs at various geo-
graphical axis angles, with the least crossings (9144) at 228.1° (Fig 2A). Although spoligotyping
might have led to minor misclassifications of MAF1/MAF2 isolates in our phylogenetic analy-
ses (S2 Fig), we expect such misclassification to result in an unbiased underestimation of the
observed geographical separation.
Longitudinal development of lineages in The Gambia
1164 consecutive TB patients were recruited between 2002–2010. Logistic regression modelling
revealed both a non-significant lineage by time interaction (p = 0.38) and a non-significant
time main effect (p = 0.80). Our analysis therefore indicated that the proportions of lineages
are stable over time. The overall lineage percentages, in order of magnitude, are Euro-Ameri-
can 57.2% (95%CI 54.4%-60.0%), MAF2 35.4% (95%CI 32.7%-38.2%), Indo-Oceanic 4.3%
(95%CI 3.3%-5.6%), East Asian (Beijing) 2.5% (95%CI 1.7%-3.6%), MAF1 1.0% (95%CI 0.4%-
2.4%) and East African Indian 0.8% (95%CI 0.2%-3.2%) (Fig 3).
Discussion
We confirmed that modern Euro-American strains are the predominant lineage followed by
the twoM. africanum lineages. Although the polyphyletic T1 family [26] is rather equally
Tuberculosis in West Africa
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Fig 1. Geospatial distribution of major mycobacterial families within each lineage in West Africa. For each of the six present lineages, the major
families are mapped. The eight overall major families highlighted with asterisks (*) cause 84% of all pulmonary TB in the region and compriseM. africanum
West Africa 1 (MAF1),M. africanumWest Africa 2 (MAF2), LAM9, LAM10, Haarlem 1, Haarlem 3 and Beijing families.
doi:10.1371/journal.pntd.0004408.g001
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Fig 2. Phylogeographic analysis of major geographically restricted families using GenGIS. A.)
Phylogeography, in which an UPGMA tree that includes MAF1, MAF2, Haarlem 3 and LAM10 spoligotypes,
is superimposed onto the geographical distribution map. Each spoligotype in the tree is linked to its actual
location on the map and the crossing-overs of connecting lines can be counted. In case of no geographical
separation crossings of the connecting lines would occur at random. If less crossings are observed than
expected by chance geographical separation occurs, as for instance, at a geographic tree axis angle of
228.1° of these major four families. B) Linear axis plot scanning for axis angles of the superimposed
phylogenetic tree onto the map, in which geographic separation occurs. The red line indicates the minimum
number of crossings that would have been expected by chance at significance level p = 0.001. Every
orientation of the tree onto the map that results in less crossings than expected by chance (9759.5) lies below
the line and indicates significant geographical separation and can be observed between 110°-131°, 151°-
170° and 217°- 270°. The most extreme geographical separation with the least crossings (9144) occurs at an
angle of 228.1° (arrow) and is plotted in 2A.
doi:10.1371/journal.pntd.0004408.g002
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distributed across the whole region, we find geographical variations of other families. While
western West Africa shows a high genetic diversity from a multitude of mycobacterial families,
the MTBc of Eastern West Africa is mainly composed of two dominant families (LAM10 and
MAF1). Although other West and Central African countries observed a replacement of MAF1
and MAF2 with modern strains [10,11,14,27], our longitudinal analysis from The Gambia did
not confirm these findings and MAF2 remains an important cause of TB in the country. The
exact mechanism of howMAF2 can maintain a stable prevalence of 35% over the last decade
within The Gambia (despite a slower progression to disease when compared toM. tuberculosis
[28]) is not fully understood.
Besides the known geographical divide of the twoM. africanum lineages, we find for the
first time geographical separation of major Euro-American families in West Africa. Due to this
spatial variation previous research findings observed in one West African country/region are
hardly generalizable to the sub-region. In addition, the unequal distribution has important
implications for design of future trials. For instance, western West African countries with their
high genetic diversity are appropriate settings for research that aims to test whether novel diag-
nostics or vaccine candidates work equally well against different MTBc families. In contrast,
research on host genetics, benefitting from low diversity, would yield more robust results when
conducted in eastern West Africa with predominant LAM10 and MAF1 families. To investi-
gate the spreading of novel TB families, one can follow up on the geographical expansion of
LAM10 or on recently introduced Beijing strains into Benin or Senegal. As first studies con-
firmed that the “ill-defined”T1 is not a monophyletic clade [26], further research using more
robust phylogenetic markers could focus on understanding the endemic MTBc composition
T1-endemic countries.
The presented phylogeography also has limitations: first, we combined genotypic informa-
tion, independent from respective collection strategies ranging from convenience to systematic
sampling. Therefore data presented are a cross-sectional compilation of genotyping informa-
tion between 1986–2012. Also, individual patient’s treatment history, whether they presented
as new or retreatment cases, was not systematically collected and has not been accounted for.
In order to avoid over-interpretation of results, we agree that comparing differing sampling
Fig 3. Longitudinal development of theM. tuberculosis complex in The Gambia between 2002–2010. 1164 smear-positive pulmonary TB isolates were
spoligotyped and assigned to lineages. We analyzed the longitudinal development of the six prevalent lineages over time, using logistic regression modelling
for grouped data. As no lineage/time interaction or time as main effect was detected, the average prevalence and 95% confidence intervals for each lineage
were estimated as follows: Euro-American: 57.2% (54.4%-60.0%);M. africanumWest Africa 2 (MAF2): 35.4% (32.7%-38.2%); Indo-Oceanic: 4.3% (3.3%-
5.6%); East Asian (Beijing): 2.5% (1.7%-3.6%);M. africanumWest Africa 1 (MAF1): 1.0% (0.4%-2.4%); East African Indian 0.8% (0.2%-3.2%).
doi:10.1371/journal.pntd.0004408.g003
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strategies is challenging, and we therefore limited our discussion to proportions of families
with larger isolate numbers. Lastly, the families themselves consist of a multitude of strains
characterised by specific spoligotypes (shared international types, SITs) and we did not study
whether the local expansion of a family was driven by one or several individual proliferating
SIT within the family.
Spoligotyping can be successfully used to assign the majority of mycobacterial isolates to
one of the major mycobacterial lineages and their families [4]. We appreciate that classification
of mycobacteria in West Africa would ideally be based on whole genome sequencing (WGS)
data, however, limited bioinformatics capacity combined with financial and infrastructural
constraints did not allow high-throughput sequencing in most resource-limited West African
countries to date.
By summarizing available and novel data, we showed significant geographical variation of
the MTBc, which will impact on the overall outcome of clinical trials in any specific region.
With the generated data researchers can consider the demonstrated spatial variation in the
planning stage of respective future clinical TB trials.
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